METTL1 and hepatocellular carcinoma: An unbiased proteomic profiling conducted on the parental and lenvatinib-resistant HCC cells revealed the significant upregulation of two key components of m7G methyltransferase complex, including METTL1 and WD repeat domain 4 protein (WDR4).